Melanoma Molecular Maps Projects

Padova

The IPD is a multicenter database, which gathers anonymized information about clinical and histopathological features as well as availability of biological material regarding patients with cutaneous melanoma enrolled by centers that participate in this project.
A systematic collection of the scientific knowledge regarding the development of targeted therapy for melanoma. Since data are gathered in a computationally compatible fashion, the database can be utilized for the identification of prevalent therapeutic hypotheses based on the available evidence and for ranking treatments based on the patient's molecular profile (drug ranking system).
Inspired to the principles of functional interactomics, this is a collection of schematic figures depicting the molecular pathways involved in cancer development and progression, with particular regard to melanoma. A close-to-hand visual guide to navigate in the ever-growing complexity of cancer molecular biology.

Search the site


Risk Assessment Tools

TNM Staging System | Total Dermoscopy Score | Thin Melanoma Prognosis |


Melanoma News

Clinicopathological features and clinical outcomes associated with TP53 and BRAFNon-V600 mutations in cutaneous melanoma patients.
Kim DW, Haydu LE, Joon AY, Bassett RL Jr, Siroy AE, Tetzlaff MT, Routbort MJ, Amaria RN, Wargo JA, McQuade JL, Kemnade J, Hwu P, Woodman SE, Roszik J, Kim KB, Gershenwald JE, Lazar AJ, Davies MA
Cancer. 2016 Dec 2;():.
PMID: 27911979 [PubMed - as supplied by publisher]

Routine X-ray of the chest is not justified in staging of cutaneous melanoma patients.
Gjørup CA, Hendel HW, Pilegaard RK, Willert CB, Hölmich LR
Dan Med J. 2016 Dec;63(12):.
PMID: 27910800 [Unknown status]

Metastatic pathways in patients with cutaneous melanoma.
Adler NR, Haydon A, McLean CA, Kelly JW, Mar VJ
Pigment Cell Melanoma Res. 2016 Oct 19;():.
PMID: 27900851 [PubMed - as supplied by publisher]

Toll-like receptors and cutaneous melanoma.
Coati I, Miotto S, Zanetti I, Alaibac M
Oncol Lett. 2016 Nov;12(5):3655-3661.
PMID: 27900049 [Unknown status]

Interval cancers after skin cancer screening: incidence, tumour characteristics and risk factors for cutaneous melanoma.
Hübner J, Waldmann A, Geller AC, Weinstock MA, Eisemann N, Noftz M, Bertram S, Nolte S, Volkmer B, Greinert R, Breitbart E, Katalinic A
Br J Cancer. 2016 Nov 29;():.
PMID: 27898656 [PubMed - as supplied by publisher]


NCBI's Disclaimer and Copyright notice